Joël J.-F. Oger: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Causes that Contribute to the Excess Mortality Risk in Multiple Sclerosis: A Population-Based Study

Kingwell, Elaine, Zhu, Feng, Evans, Charity, Duggan, Thomas, Oger, Joel, Tremlett, Helen

Journal:

Neuroepidemiology

Year:

2019

File:

PDF, 173 KB

2019

2

Où allons-nous avec les traitements de la SEP? Les coûts vont-ils continuer à augmenter ?*

Oger, Joel, AlKhawajah, Mona

Journal:

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques

Year:

2010

Language:

french

File:

PDF, 44 KB

french, 2010

3

Late-onset myasthenia gravis: A review when incidence in older adults keeps increasing

Alkhawajah, Nuha M., Oger, Joel

Journal:

Year:

2013

Language:

english

File:

PDF, 380 KB

english, 2013

4

Randomized Trial of Thymectomy in Myasthenia Gravis

Wolfe, Gil I., Kaminski, Henry J., Aban, Inmaculada B., Minisman, Greg, Kuo, Hui-Chien, Marx, Alexander, Ströbel, Philipp, Mazia, Claudio, Oger, Joel, Cea, J. Gabriel, Heckmann, Jeannine M., Evoli, Am

Journal:

New England Journal of Medicine

Year:

2016

Language:

english

File:

PDF, 277 KB

english, 2016

5

Mechanisms responsible for reduced in vitro immunoglobulin secretion in aged humans

Jack P. Antel, Joel J.-F. Oger, Lawrence G. Wrabetz, Barry G.W. Arnason, John E. Hopper

Journal:

Mechanisms of Ageing and Development

Year:

1983

Language:

english

File:

PDF, 457 KB

english, 1983

6

Secretion of Nerve Growth Factor by Central Nervous System Glioma Cells in Culture

Richard A. Murphy, Joël Oger, Judith D. Saide, Muriel H. Blanchard, Barry G. W. Arnason, Charles Hogan, Nicholas J. Pantazis and Michael Young

Journal:

The Journal of Cell Biology

Year:

1977

Language:

english

File:

PDF, 724 KB

english, 1977

7

Autosomal dominant cerebrovascular amyloidosis: Properties of peripheral blood lymphocytes

Kari Stefansson, Dr. Jack P. Antei, Joel Oger, James Burns, AvertanoB. C. Noronha, Raymond P. Roos, Barry G. W. Arnason, G. Gudmundsson

Journal:

Annals of Neurology

Year:

1980

Language:

english

File:

PDF, 427 KB

english, 1980

8

Demyelination and ethnicity: Experience at the University of British Columbia multiple sclerosis clinic with special reference to HTLV-I–associated myelopathy in British Columbian natives

Dr JoëL Oger, Helen Lai

Journal:

Annals of Neurology

Year:

1994

Language:

english

File:

PDF, 239 KB

english, 1994

9

Regulation of in vitro PWM-induced IgG secretion in humans

Maurice R.G. O'Gorman, Joel J.-F. Oger

Journal:

Cellular Immunology

Year:

1989

Language:

english

File:

PDF, 1.33 MB

english, 1989

10

Long-Term Persistence With the Immunomodulatory Drugs for Multiple Sclerosis: A Retrospective Database Study

Charity Evans, Jennifer Tam, Elaine Kingwell, Joel Oger, Helen Tremlett

Journal:

Clinical Therapeutics

Year:

2012

Language:

english

File:

PDF, 621 KB

english, 2012

11

Interferon-β downregulates interferon-γ-induced class II MHC molecule expression and morphological changes in primary cultures of human brain microvessel endothelial cells

Hanh K. Huynh, Joel Oger, Katerina Dorovinizis

Journal:

Journal of Neuroimmunology

Year:

1995

Language:

english

File:

PDF, 1.88 MB

english, 1995

12

HTLV Type I/II in British Columbia Amerindians: A Seroprevalence Study and Sequence Characterization of an HTLV Type IIa Isolate

Peters, Andrew A., Coulthart, Michael B., Oger, Joel J.F., Waters, David J., Crandall, Keith A., Baumgartner, Alexandra A.

Journal:

AIDS Research and Human Retroviruses

Year:

2000

Language:

english

File:

PDF, 335 KB

english, 2000

13

Cognitive Impairment and Depression in Mild Multiple Sclerosis

Good, Kim, Clark, Campbell M., Oger, Joel, Paty, Donald, Klonoff, Harry

Journal:

Journal of Nervous & Mental Disease

Year:

1992

File:

PDF, 344 KB

1992

14

Acetylcholine Receptor Antibodies in Myasthenia Gravis: Use of a Qualitative Assay for Diagnostic Purposes

Oger, Joel, Kaufman, Robin, Berry, Kenneth

Journal:

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques

Year:

1987

Language:

english

File:

PDF, 550 KB

english, 1987

15

In vitro acetylcholine receptor antibody (ACHRAB) production in myasthenia gravis: Nonspecific reduction with duration of disease

Robin Kaufman, Joel Oger

Journal:

Journal of Neuroimmunology

Year:

1987

Language:

english

File:

PDF, 69 KB

english, 1987

16

Synthesis of Nerve Growth Factor by L and 3T3 Cells in Culture

Joel Oger, Barry G. W. Arnason, Nicholas Pantazis, James Lehrich and Michael Young

Journal:

Proceedings of the National Academy of Sciences

Year:

1974

Language:

english

File:

PDF, 1.16 MB

english, 1974

17

Serum proteomics in multiple sclerosis disease progression

Tremlett, Helen, Dai, Darlene L.Y., Hollander, Zsuzsanna, Kapanen, Anita, Aziz, Tariq, Wilson-McManus, Janet E., Tebbutt, Scott J., Borchers, Christoph H., Oger, Joel, Cohen Freue, Gabriela V.

Journal:

Journal of Proteomics

Year:

2015

Language:

english

File:

PDF, 1.04 MB

english, 2015

18

Should neutralizing antibodies be monitored during interferon-β treatment for multiple sclerosis?

Oger, Joel, Gibbs, Ebrima

Journal:

Nature Clinical Practice Neurology

Year:

2006

Language:

english

File:

PDF, 99 KB

english, 2006

19

Tumor Growth: Suppression in Mice by Submandibular Gland Extirpation 2

Arnason, Barry G. W., Chelmicka-Szorc, Ewa, McCully, Kilmer S., Oger, Joel, Young, Michael

Journal:

JNCI Journal of the National Cancer Institute

Year:

1975

Language:

english

File:

PDF, 779 KB

english, 1975

20

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial

Wolfe, Gil I, Kaminski, Henry J, Aban, Inmaculada B, Minisman, Greg, Kuo, Hui-Chien, Marx, Alexander, Ströbel, Philipp, Mazia, Claudio, Oger, Joel, Cea, J Gabriel, Heckmann, Jeannine M, Evoli, Amelia,

Journal:

The Lancet Neurology

Year:

2019

File:

PDF, 791 KB

2019

21

HLA profiles in multiple sclerosis suggest two forms of disease and the existence of protective haplotypes

Michel Madigand, Joël J.-F. Oger, Renée Fauchet, Oliver Sabouraud, Bernard Genetet

Journal:

Journal of the Neurological Sciences

Year:

1982

Language:

english

File:

PDF, 507 KB

english, 1982

22

Amyotrophic lateral sclerosis presentation of a human T-lymphotropic virus type-1 myelopathy - insight into pathogenesis

Alkhawajah, Nuha M., Chapman, Kristine M., Moore, G. R. Wayne, Oger, Joel

Journal:

Year:

2015

Language:

english

File:

PDF, 1.13 MB

english, 2015

23

Genetic susceptibility to MS: a second stage analysis in Canadian MS families

David A. Dyment, Cristen J. Willer, Beverly Scott, Holly Armstrong, Arturs Ligers, Jan Hillert, Donald W. Paty, Stanley Hashimoto, Virginia Devonshire, John Hooge, Lorne Kastrukoff, Joel Oger, Luanne

Journal:

Year:

2001

Language:

english

File:

PDF, 47 KB

english, 2001

24

Immunogenetics of neurological diseases

Joël J.F. Oger, Barry G.W. Arnason

Journal:

Trends in Neurosciences

Year:

1979

Language:

english

File:

PDF, 355 KB

english, 1979

25

A Biosensor-Based Characterization of the Affinity Maturation of the Immune Response Against Interferon-β and Correlations with Neutralizing Antibodies in Treated Multiple Sclerosis Patients

Gibbs, Ebrima, Oger, Joel

Journal:

Journal of Interferon & Cytokine Research

Year:

2008

Language:

english

File:

PDF, 499 KB

english, 2008

26

Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme

Palace, Jacqueline, Duddy, Martin, Lawton, Michael, Bregenzer, Thomas, Zhu, Feng, Boggild, Mike, Piske, Benjamin, Robertson, Neil P, Oger, Joel, Tremlett, Helen, Tilling, Kate, Ben-Shlomo, Yoav, Lilfo

Journal:

Journal of Neurology Neurosurgery & Psychiatry

Year:

2018

Language:

english

File:

PDF, 637 KB

english, 2018

27

Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis

Chris H Polman, Antonio Bertolotto, Florian Deisenhammer, Gavin Giovannoni, Hans-Peter Hartung, Bernhard Hemmer, Joep Killestein, Henry F McFarland, Joel Oger, Andrew R Pachner, John Petkau, Anthony T

Journal:

The Lancet Neurology

Year:

2010

Language:

english

File:

PDF, 206 KB

english, 2010

28

Validating parameters of a luciferase reporter gene assay to measure neutralizing antibodies to IFNβ in multiple sclerosis patients

Regina Lam, Rachel Farrell, Tariq Aziz, Ebrima Gibbs, Gavin Giovannoni, Sidney Grossberg, Joel Oger

Journal:

Journal of Immunological Methods

Year:

2008

Language:

english

File:

PDF, 380 KB

english, 2008

29

Terbutaline in myasthenia gravis: A pilot study

Betty Soliven, Kourosh Rezania, Betul Gundogdu, Barbara Harding-Clay, Joel Oger, Barry G.W. Arnason

Journal:

Journal of the Neurological Sciences

Year:

2009

Language:

english

File:

PDF, 464 KB

english, 2009

30

HTLV-1 infection and the viral etiology of multiple sclerosis

Journal:

Journal of the Neurological Sciences

Year:

2007

Language:

english

File:

PDF, 122 KB

english, 2007

31

HTLV-I Associated Myelopathy: A Case of Viral-Induced Auto-Immunity

Oger, Joël, Phd, Gregory Dekaban

Journal:

Year:

1995

Language:

english

File:

PDF, 1.10 MB

english, 1995

32

Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis

Shirani, Afsaneh, Zhao, Yinshan, Karim, Mohammad Ehsanul, Evans, Charity, Kingwell, Elaine, van der Kop, Mia L., Oger, Joel, Gustafson, Paul, Petkau, John, Tremlett, Helen

Journal:

JAMA The Journal of the American Medical Association

Year:

2012

Language:

english

File:

PDF, 391 KB

english, 2012

33

MRI Contributes to the Differentiation Between MS and HTLV-I Associated Myelopathy in British Columbian Coastal Natives

Howard, Andrew K., Li, David K.B., Oger, Joël

Journal:

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques

Year:

2003

File:

PDF, 787 KB

2003

34

During 3 years treatment of primary progressive multiple sclerosis with glatiramer acetate, specific antibodies switch from IgG1 to IgG4

Erika Basile, Ebrima Gibbs, Tariq Aziz, Joel Oger

Journal:

Journal of Neuroimmunology

Year:

2006

Language:

english

File:

PDF, 203 KB

english, 2006

35

The IgG subclass-specificities of anti-IFNβ antibodies change with time and differ between the IFNβ products in relapsing remitting multiple sclerosis patients

Ebrima Gibbs, Joel Oger

Journal:

Journal of Neuroimmunology

Year:

2007

Language:

english

File:

PDF, 277 KB

english, 2007

36

Short-term and long-term safety and tolerability of interferon β-1b in multiple sclerosis

Reder, Anthony T., Oger, Joel F., Kappos, Ludwig, O’Connor, Paul, Rametta, Mark

Journal:

Multiple Sclerosis and Related Disorders

Year:

2014

Language:

english

File:

PDF, 645 KB

english, 2014

37

Indications for Interferon Beta 1B Treatment in Multiple Sclerosis

Journal:

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques

Year:

1995

Language:

english

File:

PDF, 69 KB

english, 1995

38

Modulation of T lymphocyte differentiation antigens: Influence of aging

Maureen Rosenkoetter, Jack P. Antel, Joel J-F. Oger

Journal:

Cellular Immunology

Year:

1983

Language:

english

File:

PDF, 463 KB

english, 1983

39

Immunosuppression: Promises and failures

Journal:

Journal of the Neurological Sciences

Year:

2007

Language:

english

File:

PDF, 124 KB

english, 2007

40

[Part 1: Biological Sciences] || Modulation of T-lymphocyte Differentiation Antigens: Potential Relevance for Multiple Sclerosis

Jack Antel, Joel J.-F. Oger, Susanne Jackevicius, Han Hwa Kuo and Barry G. W. Arnason

Journal:

Proceedings of the National Academy of Sciences

Year:

1982

Language:

english

File:

PDF, 897 KB

english, 1982

41

DMDs Are an Essential Issue But Are They the Only Issue in MS Treatment?

Shahbeigi, Saeed, Oger, Joel

Journal:

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques

Year:

2013

Language:

english

File:

PDF, 33 KB

english, 2013

42

An apparent case of human T-cell lymphotropic virus type II (HTLV-II)-associated neurological disease: a clinical, molecular, and phylogenetic characterisation

Andrew A Peters, Joel J.F Oger, Michael B Coulthart, David J Waters, Heather J Cummings, Gregory A Dekaban

Journal:

Journal of Clinical Virology

Year:

1999

Language:

english

File:

PDF, 365 KB

english, 1999

43

Neutralising Antibodies to Interferon-β in the Treatment of Multiple Sclerosis

Beatrix Paszner,John Petkau,Dr Joël Oger

Journal:

Year:

1999

Language:

english

File:

PDF, 317 KB

english, 1999

44

Antibody dissociation rates are predictive of neutralizing antibody (NAb) course: A comparison of interferon beta-1b-treated Multiple Sclerosis (MS) patients with transient versus sustained NAbs

Gibbs, Ebrima, Karim, Mohammad Ehsanul, Oger, Joel

Journal:

Clinical Immunology

Year:

2015

Language:

english

File:

PDF, 1.01 MB

english, 2015

45

Association between beta-interferon exposure and hospital events in multiple sclerosis

Evans, Charity, Zhu, Feng, Kingwell, Elaine, Shirani, Afsaneh, van der Kop, Mia L., Petkau, John, Gustafson, Paul, Zhao, Yinshan, Oger, Joel, Tremlett, Helen

Journal:

Pharmacoepidemiology and Drug Safety

Year:

2014

Language:

english

File:

PDF, 439 KB

english, 2014

46

Cell-mediated immunity in idiopathic polyneuritis

Dr. Aleem Iqbal, Joel J.-F. Oger, Barry G. W. Arnason

Journal:

Annals of Neurology

Year:

1981

Language:

english

File:

PDF, 532 KB

english, 1981

47

Influence of azathioprine (Imuran) on in vitro immune function in multiple sclerosis

Dr. Joel J.-F. Oger, Jack P. Antel, Han Hwa Kuo, Barry G. W. Arnason

Journal:

Annals of Neurology

Year:

1982

Language:

english

File:

PDF, 488 KB

english, 1982

48

Interferons in relapsing remitting multiple sclerosis

Mark Freedman, John King, Joel Oger, Mohammad Sharief, Hans-Peter Hartung

Journal:

Year:

2003

Language:

english

File:

PDF, 60 KB

english, 2003

49

The implications of immunogenicity for protein-based multiple sclerosis therapies

Bruce A. Cohen, Joel Oger, Alison Gagnon, Gavin Giovannoni

Journal:

Journal of the Neurological Sciences

Year:

2008

Language:

english

File:

PDF, 639 KB

english, 2008

50

Neutralizing antibodies in multiple sclerosis patients on weekly intramuscular Avonex and biosimilar interferon beta-1a (CinnoVex): Comparing results of measurements in two different laboratories

Shahkarami, Mohammad Amir, Vaziri, Behrouz, Salami, Shiva, Harandi, Ali Amini, Oger, Joel

Journal:

Journal of Immunological Methods

Year:

2013

Language:

english

File:

PDF, 159 KB

english, 2013

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски